Meet the 13 Members of Biden’s COVID-19 Task Force

Nov 9, 2020 | COVID-19, COVID-19 Task Force, News, Popular Posts

Meet the 13 members of Biden's COVID-19 Task Force

President-elect Joe Biden is convening a task force of 13 physicians and health experts to help guide his COVID-19 response strategy.

The Transition COVID-19 Advisory Board includes three co-chairs and 10 members who will work with health officials nationwide to create policies to address the virus’s spread, help eliminate health disparities and reopen schools and businesses, reports The Washington Post.

Taskforce co-chairs:

  • Vivek Murthy, MD, U.S. surgeon general during the Obama administration
  • David Kessler, MD, former FDA commissioner under Presidents George H.W. Bush and Bill Clinton
  • Marcella Nunez-Smith, MD, associate dean for health equity research at the Yale School of Medicine in New Haven, Conn.

Taskforce members:

  • Zeke Emanuel, MD, PhD, chair of the department of medical ethics and health policy at the University of Pennsylvania in Philadelphia 
  • Atul Gawande, MD, a surgeon at Boston-based Brigham and Women’s Hospital and a professor at Harvard Medical School 
  • Michael Osterholm, PhD, director of the Center for Infectious Disease Research and Policy at the University of Minnesota in Minneapolis
  • Rick Bright, PhD, former director of the Biomedical Advanced Research and Development Authority
  • Eric Goosby, MD, global AIDS coordinator under former President Barack Obama and professor of medicine at UCSF School of Medicine
  • Celine Gounder, MD, clinical assistant professor of medicine and infectious diseases at New York University’s Grossman School of Medicine in New York City
  • Julie Morita, MD, executive vice president of the Robert Wood Johnson Foundation
  • Loyce Pace, president and executive director of the Global Health Council
  • Robert Rodriguez, MD, professor of emergency medicine at the UCSF School of Medicine
  • Luciana Borio, former director for medical and biodefense preparedness on President Donald Trump’s National Security Council 

Two additional health experts will serve as advisors:

  • Rebecca Katz, PhD, director of the Center for Global Health Science and Security at Georgetown University Medical Center in Washington, D.C.
  • Beth Cameron, PhD, former director for global health security and biodefense on the White House National Security Council during the Obama administration


  1. Tom Woods

    Suggest they investigate leronlimab, a monoclonal antibody produced by Cytodyn in Vancouver, WA, USA.
    Leronlimab is in Phase 3 FDA trials for patients with severe/critical COVID-19.
    The company is in discussions with several countries to help treat the virus.
    The world needs this medication NOW.

    • TL

      Couldn’t agree more! Leronlimab works on Covid19. EUA NOW!

  2. brett sewell

    Ivermectin should not be overlooked

  3. Ibrahim Champion

    Ivermectin should be promoted, it’s been proven to work both as a prophylactic and as d prescriptive treatment and it’s got a proven safety record.

    The Dosages needed are known and even if larger dosages are taken there is no recorded danger.

    and it’s cheap and readily available – millions of doses can be produced very quickly.

    It’s cheapness is one of the tings that has been holding it back – it’s patent has expired and no-one can make big bucks from it.

    A triple treatment pioneered by Prof Thomas Borody in Sydney, Australia uses Ivermectin as the anti SARS-CoV-2 agent plus Zinc to strengthen the imune system plus Doxycycline as an antibiotic to control any bacterial upcharge following on the viral infection. AND IT WORKS !!! iT IS being tested in an RCT in Florida at this moment and an RCT trial in Bangladesh is now in pre-print.

    All this info and more has been published in TrialSirte News.

    Insistance on further RCTs would seem to run counter to the Physicians oath to do no harm viz: in the Bangladesh RCT those taking the ivermectin all recovered and quickly and none died by comparison with those on the placebo THREE OF WHOM DIED. Why is it necessary to condemn patients to die in an RCT lottery to prove something that we already know viz: THAT IVERMECTIN WORKS, it is cheap and is readily available and millions more doses can be produced very quickly.

    • ML

      The sad fact is, it does not appear that the USA at least, is desiring of cheap and readily available solutions like ivermectin. It’s a travesty that while the glitterati of the Medico-Pharma complex chase vaccines that may not be ultimately proven safe, and expensive therapeutics that are only given in a hospital setting once people are quite ill, that tens of thousands of people will continue to die from their inaction. It’s unethical, immoral, criminal, and obviously driven by the greed of Wall St “investors” and their cohorts and lackeys in government. I’ve lost complete faith in the U.S. government to help their citizens. Meanwhile, we rely on doctors like Paul Marik and his entire group to advocate for people everywhere. I certainly send each of his lectures to everyone I know. The truth will out!

  4. Dr Muhammad Moinuddin MBBS, DPH, M.Phil. ( PSM)

    I have prescribed Ivermectin +Doxycycline/Azithromycin+Zinc to suspected COVID-19 patients with 100% cure rate. I have traveled by air for 24 hrs + 24 hrs return journey by Qatar Airways , where, actually it was not possible to maintain social distancing and keep mask all the time. We 200 to 300 passengers had to eat, drink, share the toilets.
    I used to take Ivermectin 15 mg day before doing the test for rtPCR (mandatory for passengers) not before 72 hours of departure.
    Other passengers who were worried about the journey and rtPCR tests also was advised to take the same precautions and none caught the virus.
    Three times rt PCR tests were negative.
    Ivermectin has prophylactic properties to block the SARS-COV-2 virus from multiplying.

Pin It on Pinterest